Distinct proteomic and post-translational impacts of class-defining AML alterations To explore the imprint of recurrent genetic alterations on the AML proteome, we linked common genetic alterations to differences in the abundance of proteins and PTMs (Methods)
Most clinical study of CJC-1295 has measured its effect on GH and IGF-1 levels rather than on long-term body-composition or anti-aging endpoints
Retatrutide has no MHRA marketing authorisation and is only accessible within authorised clinical trials
Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice
Cell viability was assessed 3 days after treatment with FOXO4-DRI at 0, 12.5, 25, 50, and 100 M, respectively, using the Cell Counting Kit-8 (CCK-8) Assay (Dojindo, Rockville, MD, United States)
Impact of ACSL4 on the prognosis of hepatocellular carcinoma: Association with cancer-associated fibroblasts and the tumour immune microenvironment